These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27885509)

  • 1. Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship.
    Lim HJ; Nguyen TT; Kim NM; Park JS; Jang TS; Kim D
    Biotechnol Lett; 2017 Mar; 39(3):415-421. PubMed ID: 27885509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through
    Yadav R; Selvaraj C; Aarthy M; Kumar P; Kumar A; Singh SK; Giri R
    J Biomol Struct Dyn; 2021 Jan; 39(1):272-284. PubMed ID: 31920173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
    Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
    Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.
    Mirza MU; Alanko I; Vanmeert M; Muzzarelli KM; Salo-Ahen OMH; Abdullah I; Kovari IA; Claes S; De Jonghe S; Schols D; Schinazi RF; Kovari LC; Trant JF; Ahmad S; Froeyen M
    Eur J Pharm Sci; 2022 Aug; 175():106220. PubMed ID: 35618201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Structure of the Zika Virus Protease, NS2B/NS3
    Hilgenfeld R; Lei J; Zhang L
    Adv Exp Med Biol; 2018; 1062():131-145. PubMed ID: 29845530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
    Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
    Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
    Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
    Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity.
    Xing H; Xu S; Jia F; Yang Y; Xu C; Qin C; Shi L
    Virus Res; 2020 Jan; 275():197793. PubMed ID: 31676367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection.
    da Silva Sanches PR; de Campos Faria JCE; Bittar C; Guberovich Olivieri HAS; de Moraes Roso Mesquita NC; Noske GD; de Godoy AS; Oliva G; Rahal P; Cilli EM
    Protein Pept Lett; 2024; 31(7):532-543. PubMed ID: 39039677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Bispecific Lead Compounds from
    Kumar S; El-Kafrawy SA; Bharadwaj S; Maitra SS; Alandijany TA; Faizo AA; Khateb AM; Dwivedi VD; Azhar EI
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
    Coronado MA; Eberle RJ; Bleffert N; Feuerstein S; Olivier DS; de Moraes FR; Willbold D; Arni RK
    Antiviral Res; 2018 Dec; 160():118-125. PubMed ID: 30393012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of unlinked NS2B-NS3 protease from Zika virus.
    Zhang Z; Li Y; Loh YR; Phoo WW; Hung AW; Kang C; Luo D
    Science; 2016 Dec; 354(6319):1597-1600. PubMed ID: 27940580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection.
    Zou M; Liu H; Li J; Yao X; Chen Y; Ke C; Liu S
    Biochem Pharmacol; 2020 Jul; 177():113962. PubMed ID: 32272109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease.
    Akaberi D; Chinthakindi PK; Båhlström A; Palanisamy N; Sandström A; Lundkvist Å; Lennerstrand J
    J Biomol Struct Dyn; 2020 Nov; 38(18):5526-5536. PubMed ID: 31880199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B/NS3 proteases.
    Maus H; Barthels F; Hammerschmidt SJ; Kopp K; Millies B; Gellert A; Ruggieri A; Schirmeister T
    Bioorg Med Chem; 2021 Oct; 47():116392. PubMed ID: 34509861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
    Starvaggi J; Previti S; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased activity of unlinked Zika virus NS2B/NS3 protease compared to linked Zika virus protease.
    Kuiper BD; Slater K; Spellmon N; Holcomb J; Medapureddy P; Muzzarelli KM; Yang Z; Ovadia R; Amblard F; Kovari IA; Schinazi RF; Kovari LC
    Biochem Biophys Res Commun; 2017 Oct; 492(4):668-673. PubMed ID: 28342876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.